首页 > 最新文献

Anesthesiology and Pain Medicine最新文献

英文 中文
Comparison of Epidural Bupivacaine and Buprenorphine to Bupivacaine and Butorphanol for Postoperative Analgesia in Lower Limb Orthopedic Surgery. 硬膜外布比卡因、丁丙诺啡与布比卡因、布托啡诺用于下肢骨科术后镇痛的比较。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-132686
Sujay Jn, Prakash Bc, Likhitha Mohan Savitha, Riyaj Ahmad Kalaburgi

Background: Postoperative analgesia is of utmost importance in the treatment of patients undergoing surgery. Good postoperative pain management reduces hospital stay and improves early ambulation. This study compared the efficacy of epidural bupivacaine with buprenorphine to butorphanol in lower limb orthopedic surgery.

Objectives: This study was carried out to investigate the onset of analgesia, the extent of analgesia, sedation score, and side effects of butorphanol with bupivacaine versus buprenorphine with bupivacaine.

Methods: In a clinical trial study, 100 patients who underwent elective orthopedic lower limb surgery were randomly allocated to two groups. A total of 100 patients with American Society of anesthesiologists grades I and II posted for lower limb orthopedic surgery were enrolled in this randomized, double-blind study. The patients were divided into groups A and B. Subarachnoid block was achieved with 3.4 mL of 0.5% bupivacaine. The pain was monitored by the visual analog scale postoperatively. The patients in group A received bupivacaine with buprenorphine, and group B received bupivacaine with butorphanol when they complained of pain in the postoperative period. The onset of analgesia, duration of analgesia, sedation score, and side effects were compared between the two groups.

Results: The onset of analgesia was observed earlier in group A than in group B (7.7 ± 1.6 vs. 12.6 ± 1.7 minutes, P < 0.001). The duration of analgesia was longer in group A than in group B (590 ± 40 vs. 480 ± 54 minutes, P < 0.001). Pulse rates and mean arterial pressures were significantly different (P < 0.001). Side effects were common in both groups.

Conclusions: Buprenorphine added to bupivacaine provides earlier onset and longer postoperative epidural analgesia than epidural butorphanol with bupivacaine.

背景:术后镇痛对手术患者的治疗至关重要。良好的术后疼痛管理可减少住院时间,提高早期活动能力。本研究比较了硬膜外布比卡因、丁丙诺啡和丁托啡诺在下肢骨科手术中的疗效。目的:研究丁托啡诺联合布比卡因与丁丙诺啡联合布比卡因的镇痛起效、镇痛程度、镇静评分及副作用。方法:在临床试验研究中,将100例择期下肢骨科手术患者随机分为两组。在这项随机双盲研究中,共有100名美国麻醉师学会I级和II级下肢骨科手术患者入选。将患者分为A组和b组,给予3.4 mL 0.5%布比卡因蛛网膜下腔阻滞。术后采用视觉模拟评分法监测疼痛情况。A组患者术后主诉疼痛时采用布比卡因联合丁丙诺啡,B组患者术后主诉疼痛时采用布比卡因联合布托啡诺。比较两组患者的镇痛时间、镇痛持续时间、镇静评分及不良反应。结果:A组镇痛起效时间明显早于B组(7.7±1.6 vs. 12.6±1.7 min, P < 0.001)。镇痛时间A组明显长于B组(590±40 vs 480±54 min, P < 0.001)。脉搏率和平均动脉压差异有统计学意义(P < 0.001)。副作用在两组中都很常见。结论:丁丙诺啡联合布比卡因比布比卡因联合布比卡因的硬膜外镇痛起效更早,术后镇痛时间更长。
{"title":"Comparison of Epidural Bupivacaine and Buprenorphine to Bupivacaine and Butorphanol for Postoperative Analgesia in Lower Limb Orthopedic Surgery.","authors":"Sujay Jn,&nbsp;Prakash Bc,&nbsp;Likhitha Mohan Savitha,&nbsp;Riyaj Ahmad Kalaburgi","doi":"10.5812/aapm-132686","DOIUrl":"https://doi.org/10.5812/aapm-132686","url":null,"abstract":"<p><strong>Background: </strong>Postoperative analgesia is of utmost importance in the treatment of patients undergoing surgery. Good postoperative pain management reduces hospital stay and improves early ambulation. This study compared the efficacy of epidural bupivacaine with buprenorphine to butorphanol in lower limb orthopedic surgery.</p><p><strong>Objectives: </strong>This study was carried out to investigate the onset of analgesia, the extent of analgesia, sedation score, and side effects of butorphanol with bupivacaine versus buprenorphine with bupivacaine.</p><p><strong>Methods: </strong>In a clinical trial study, 100 patients who underwent elective orthopedic lower limb surgery were randomly allocated to two groups. A total of 100 patients with American Society of anesthesiologists grades I and II posted for lower limb orthopedic surgery were enrolled in this randomized, double-blind study. The patients were divided into groups A and B. Subarachnoid block was achieved with 3.4 mL of 0.5% bupivacaine. The pain was monitored by the visual analog scale postoperatively. The patients in group A received bupivacaine with buprenorphine, and group B received bupivacaine with butorphanol when they complained of pain in the postoperative period. The onset of analgesia, duration of analgesia, sedation score, and side effects were compared between the two groups.</p><p><strong>Results: </strong>The onset of analgesia was observed earlier in group A than in group B (7.7 ± 1.6 vs. 12.6 ± 1.7 minutes, P < 0.001). The duration of analgesia was longer in group A than in group B (590 ± 40 vs. 480 ± 54 minutes, P < 0.001). Pulse rates and mean arterial pressures were significantly different (P < 0.001). Side effects were common in both groups.</p><p><strong>Conclusions: </strong>Buprenorphine added to bupivacaine provides earlier onset and longer postoperative epidural analgesia than epidural butorphanol with bupivacaine.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e132686"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/cb/aapm-13-2-132686.PMC10461383.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10122600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fast-Acting Sub-perception Spinal Cord Stimulation for a Case of Painful Diabetic Polyneuropathy. Just an Antalgic Treatment or Even a Therapy? 快速作用亚知觉脊髓刺激治疗疼痛性糖尿病多发性神经病1例。仅仅是止痛治疗还是治疗?
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-134901
Ezio Amorizzo, Francesca De Sanctis, Gianni Colini Baldeschi

Introduction: Painful diabetic polyneuropathy (P-DPN) occurs in 20% - 30% of diabetic patients. Currently, therapeutic strategies include lifestyle modifications, good glycemic control, and neuropathic pain drugs. Spinal cord stimulation (SCS) has been shown to be successful in patients who have not responded to other treatments. The American Diabetes Association strongly recommends early screening and diagnosis for this condition through clinical tests and nerve conduction study (NCS). In recent years, high-resolution ultrasonography (HRUS) with the analysis of cross-sectional area (CSA) has shown an increasingly important role in detecting changes in the nervous structures, blood vessels, echo, and mobility of the nerve. Cross-sectional area is frequently enlarged in these patients, even those with normal NCS. We aimed to use SCS with fast-acting sub-perception therapy (FAST) modality to treat P-DPN. We also evaluated the CSA of the involved nerves before and after treatment.

Case presentation: A 58-year-old female patient was referred to our hospital in 2020 (Civitavecchia, Italy). She suffered from P-DPN for 3 years and did not respond to conventional medical treatments. Preoperative electromyography (EMG) was negative for radiculopathy, while electroneurography (ENG) showed a reduction in sensory conduction velocity (SCV) in the sural nerve (SN) bilaterally. Clinical tests on perceived pain and quality of life showed high severity. The report was confirmed by HRUS with enlargement of the CSA of the posterior tibial nerve (PTN), external popliteal nerve (EPN), and SN. The patient was successfully subjected to all-in-one SCS implantation in the FAST modality. She obtained immediate pain relief that remained unaltered at the 3-month follow-up. The patient completely discontinued drug therapy. One month after implantation, ENG highlighted an increased SN SCV, and the HRUS of PTN EPN and SN showed a significant reduction in CSA in all 3 nerves involved.

Conclusions: Early diagnosis and treatment are crucial in improving the clinical outcome of P-DPN, but there is still no gold standard therapy. Spinal cord stimulation in the new FAST modality was effective in this clinical case. The pain relief was supported by a significant reduction in the CSA of the studied nerves observed on HRUS 1 month after SCS implantation. The results and the improvement of a pathological nervous pattern, albeit with a short follow-up of only 3 months, could suggest not only a symptomatic but perhaps also a therapeutic role of SCS in P-DPN.

疼痛性糖尿病多发神经病变(P-DPN)发生在20% - 30%的糖尿病患者中。目前,治疗策略包括改变生活方式,良好的血糖控制和神经性疼痛药物。脊髓刺激(SCS)已被证明是成功的患者对其他治疗没有反应。美国糖尿病协会强烈建议通过临床试验和神经传导研究(NCS)对这种情况进行早期筛查和诊断。近年来,高分辨率超声成像(HRUS)结合横断面积分析(CSA)在检测神经结构、血管、回声和神经活动的变化方面显示出越来越重要的作用。这些患者的横截面积经常增大,即使是NCS正常的患者。我们的目标是使用SCS与快速亚知觉治疗(FAST)方式治疗P-DPN。我们还评估了治疗前后受累神经的CSA。病例介绍:一名58岁女性患者于2020年转诊至我院(意大利奇维塔韦基亚)。她患有P-DPN 3年,对常规药物治疗无效。术前肌电图(EMG)为神经根病阴性,而神经电图(ENG)显示双侧腓肠神经(SN)感觉传导速度(SCV)降低。对感知疼痛和生活质量的临床测试显示其严重程度很高。该报告经HRUS证实,胫后神经(PTN)、腘外神经(EPN)和SN的CSA增大。患者在FAST模式下成功接受了all-in-one SCS植入。在3个月的随访中,她立即获得疼痛缓解,并保持不变。病人完全停止了药物治疗。植入1个月后,ENG显示SN SCV升高,PTN EPN和SN HRUS显示所有3条受累神经的CSA均显著降低。结论:早期诊断和治疗对改善P-DPN的临床预后至关重要,但目前尚没有金标准治疗方法。在这个临床病例中,新的FAST模式的脊髓刺激是有效的。在SCS植入1个月后,HRUS观察到所研究神经的CSA显著减少,这也支持了疼痛的缓解。结果和病理性神经模式的改善,尽管只有短短的3个月的随访,可能表明SCS在P-DPN中不仅有症状作用,而且可能有治疗作用。
{"title":"Fast-Acting Sub-perception Spinal Cord Stimulation for a Case of Painful Diabetic Polyneuropathy. Just an Antalgic Treatment or Even a Therapy?","authors":"Ezio Amorizzo,&nbsp;Francesca De Sanctis,&nbsp;Gianni Colini Baldeschi","doi":"10.5812/aapm-134901","DOIUrl":"https://doi.org/10.5812/aapm-134901","url":null,"abstract":"<p><strong>Introduction: </strong>Painful diabetic polyneuropathy (P-DPN) occurs in 20% - 30% of diabetic patients. Currently, therapeutic strategies include lifestyle modifications, good glycemic control, and neuropathic pain drugs. Spinal cord stimulation (SCS) has been shown to be successful in patients who have not responded to other treatments. The American Diabetes Association strongly recommends early screening and diagnosis for this condition through clinical tests and nerve conduction study (NCS). In recent years, high-resolution ultrasonography (HRUS) with the analysis of cross-sectional area (CSA) has shown an increasingly important role in detecting changes in the nervous structures, blood vessels, echo, and mobility of the nerve. Cross-sectional area is frequently enlarged in these patients, even those with normal NCS. We aimed to use SCS with fast-acting sub-perception therapy (FAST) modality to treat P-DPN. We also evaluated the CSA of the involved nerves before and after treatment.</p><p><strong>Case presentation: </strong>A 58-year-old female patient was referred to our hospital in 2020 (Civitavecchia, Italy). She suffered from P-DPN for 3 years and did not respond to conventional medical treatments. Preoperative electromyography (EMG) was negative for radiculopathy, while electroneurography (ENG) showed a reduction in sensory conduction velocity (SCV) in the sural nerve (SN) bilaterally. Clinical tests on perceived pain and quality of life showed high severity. The report was confirmed by HRUS with enlargement of the CSA of the posterior tibial nerve (PTN), external popliteal nerve (EPN), and SN. The patient was successfully subjected to all-in-one SCS implantation in the FAST modality. She obtained immediate pain relief that remained unaltered at the 3-month follow-up. The patient completely discontinued drug therapy. One month after implantation, ENG highlighted an increased SN SCV, and the HRUS of PTN EPN and SN showed a significant reduction in CSA in all 3 nerves involved.</p><p><strong>Conclusions: </strong>Early diagnosis and treatment are crucial in improving the clinical outcome of P-DPN, but there is still no gold standard therapy. Spinal cord stimulation in the new FAST modality was effective in this clinical case. The pain relief was supported by a significant reduction in the CSA of the studied nerves observed on HRUS 1 month after SCS implantation. The results and the improvement of a pathological nervous pattern, albeit with a short follow-up of only 3 months, could suggest not only a symptomatic but perhaps also a therapeutic role of SCS in P-DPN.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e134901"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/e1/aapm-13-2-134901.PMC10389032.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9980135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Immersive Virtual Reality on Patient Anxiety During Surgery Under Regional Anesthesia: A Randomized Clinical Trial. 沉浸式虚拟现实对区域麻醉下手术患者焦虑的影响:一项随机临床试验。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-130790
Johan Arifin, Mochamat Mochamat, Taufan Pramadika, Dina Paramita, Widya Istanto Nurcahyo

Background: Surgery and anesthesia are associated with increased patient anxiety. Perioperative anxiety is a common problem in regional anesthesia procedures and has an extensive impact. Immersive virtual reality (IVR) is a potential non-pharmacological distraction method to reduce anxiety. Immersive virtual reality creates a virtual environment that allows patients to interact and immerse in the virtual world, reducing patient anxiety.

Objectives: This study aimed to examine the effect of IVR on the anxiety of patients undergoing regional anesthetic surgery.

Methods: A total of 30 participants referred to Dr. Kariadi General Hospital (Indonesia) from October 2021 to December 2021 were enrolled in this randomized, single-blind clinical trial. The patients were divided into virtual reality (VR) and control groups (n = 15 in each group). The control group received midazolam (0.02 mg/kg) as premedication. The VR group received an IVR intervention without premedication. The data of anxiety scores were assessed using the Spielberger State-Trait Anxiety Inventory 6 (STAI-6). This study also collected vital signs, side effects, and patient and surgeon satisfaction level data.

Results: The average anxiety level during surgery in the operating room decreased in both groups (P < 0.05); the VR group had a lower score (P = 0.04). A significant reduction in perioperative anxiety levels was observed in the VR group compared to the control group. The patient satisfaction level was also significantly higher in the VR group than in the control group (P = 0.024). Both groups had no significant difference in monitored vital signs, side effects, and surgeon satisfaction.

Conclusions: The IVR intervention could reduce anxiety in patients undergoing surgery under regional anesthesia and improve patient satisfaction.

背景:手术和麻醉与患者焦虑增加有关。围手术期焦虑是区域麻醉过程中常见的问题,具有广泛的影响。沉浸式虚拟现实(IVR)是一种潜在的非药物分散注意力的方法,以减少焦虑。沉浸式虚拟现实创造了一个虚拟环境,让患者可以互动,沉浸在虚拟世界中,减少患者的焦虑。目的:本研究旨在探讨IVR对区域麻醉手术患者焦虑的影响。方法:共有30名患者于2021年10月至2021年12月在Dr. Kariadi总医院(印度尼西亚)进行了这项随机、单盲临床试验。将患者分为虚拟现实组(VR)和对照组(每组15例)。对照组给予咪达唑仑(0.02 mg/kg)作前用药。VR组接受IVR干预,没有预先用药。焦虑评分数据采用Spielberger状态-特质焦虑量表6 (STAI-6)进行评估。本研究还收集了生命体征、副作用、患者和外科医生满意度数据。结果:两组患者术中平均焦虑水平均降低(P < 0.05);VR组得分较低(P = 0.04)。与对照组相比,VR组围手术期焦虑水平显著降低。VR组患者满意度显著高于对照组(P = 0.024)。两组在监测的生命体征、副作用和外科医生满意度方面无显著差异。结论:IVR干预可减少区域麻醉下手术患者的焦虑,提高患者满意度。
{"title":"Effects of Immersive Virtual Reality on Patient Anxiety During Surgery Under Regional Anesthesia: A Randomized Clinical Trial.","authors":"Johan Arifin,&nbsp;Mochamat Mochamat,&nbsp;Taufan Pramadika,&nbsp;Dina Paramita,&nbsp;Widya Istanto Nurcahyo","doi":"10.5812/aapm-130790","DOIUrl":"https://doi.org/10.5812/aapm-130790","url":null,"abstract":"<p><strong>Background: </strong>Surgery and anesthesia are associated with increased patient anxiety. Perioperative anxiety is a common problem in regional anesthesia procedures and has an extensive impact. Immersive virtual reality (IVR) is a potential non-pharmacological distraction method to reduce anxiety. Immersive virtual reality creates a virtual environment that allows patients to interact and immerse in the virtual world, reducing patient anxiety.</p><p><strong>Objectives: </strong>This study aimed to examine the effect of IVR on the anxiety of patients undergoing regional anesthetic surgery.</p><p><strong>Methods: </strong>A total of 30 participants referred to Dr. Kariadi General Hospital (Indonesia) from October 2021 to December 2021 were enrolled in this randomized, single-blind clinical trial. The patients were divided into virtual reality (VR) and control groups (n = 15 in each group). The control group received midazolam (0.02 mg/kg) as premedication. The VR group received an IVR intervention without premedication. The data of anxiety scores were assessed using the Spielberger State-Trait Anxiety Inventory 6 (STAI-6). This study also collected vital signs, side effects, and patient and surgeon satisfaction level data.</p><p><strong>Results: </strong>The average anxiety level during surgery in the operating room decreased in both groups (P < 0.05); the VR group had a lower score (P = 0.04). A significant reduction in perioperative anxiety levels was observed in the VR group compared to the control group. The patient satisfaction level was also significantly higher in the VR group than in the control group (P = 0.024). Both groups had no significant difference in monitored vital signs, side effects, and surgeon satisfaction.</p><p><strong>Conclusions: </strong>The IVR intervention could reduce anxiety in patients undergoing surgery under regional anesthesia and improve patient satisfaction.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e130790"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c4/11/aapm-13-2-130790.PMC10461385.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10119715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Management of Incidental Uncontrolled Elevation of Intraoperative Blood Pressure: A Comparative Study on Nitroglycerine Versus Dexmedetomidine Infusion. 术中意外血压升高不受控制的处理:硝酸甘油与右美托咪定输注的比较研究。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-134806
Walaa Y Elsabeeny, Nahla N Shehab, Mostafa A Ibrahim, Eman D El Desouky, Sayed M Abed

Background: Uncontrolled elevation of intraoperative blood pressure can result in deleterious effects with increased risk of morbidity and mortality.

Objectives: We aimed to compare nitroglycerine infusion with dexmedetomidine infusion in controlling accidental intraoperative uncontrolled hypertension.

Methods: This comparative study was conducted on 73 hypertensive patients undergoing cancer surgeries who experienced uncontrolled intraoperative hypertension. The data of 38 patients were retrieved from the medical records for the nitroglycerine group and 35 patients were prospectively enrolled for the dexmedetomidine group. Group N received nitroglycerine infusion (0.3 - 1 µg/kg/min), while group D received dexmedetomidine infusion (0.2 - 0.7 µg/kg/h).

Results: Both groups were comparable regarding their demographic data and clinical characteristics. Systolic, diastolic, and mean arterial pressure (MAP) values were significantly lower in group N compared to group D during the period between 60 and 120 minutes intraoperatively (P < 0.001). Heart rate values were significantly lower in group D than in group N (P < 0.001). Postoperative sedation scores were better for group D with lower analgesic requirements (P < 0.001).

Conclusions: Dexmedetomidine infusion can be used to manage the uncontrolled intraoperative elevation of blood pressure in selected patient population.

背景:术中血压升高不受控制可导致有害影响,增加发病率和死亡率的风险。目的:比较硝酸甘油输注与右美托咪定输注对术中意外不可控高血压的控制作用。方法:对73例接受肿瘤手术且术中高血压未得到控制的高血压患者进行对比研究。从医疗记录中检索到38例硝酸甘油组患者的数据,35例患者被纳入右美托咪定组。N组输注硝酸甘油(0.3 ~ 1µg/kg/min), D组输注右美托咪定(0.2 ~ 0.7µg/kg/h)。结果:两组在人口学数据和临床特征方面具有可比性。术中60 ~ 120分钟内,N组的收缩压、舒张压和平均动脉压(MAP)值明显低于D组(P < 0.001)。D组患者心率值显著低于N组(P < 0.001)。D组术后镇静评分较好,镇痛需求较低(P < 0.001)。结论:右美托咪定输注可用于控制患者术中血压升高。
{"title":"Management of Incidental Uncontrolled Elevation of Intraoperative Blood Pressure: A Comparative Study on Nitroglycerine Versus Dexmedetomidine Infusion.","authors":"Walaa Y Elsabeeny,&nbsp;Nahla N Shehab,&nbsp;Mostafa A Ibrahim,&nbsp;Eman D El Desouky,&nbsp;Sayed M Abed","doi":"10.5812/aapm-134806","DOIUrl":"https://doi.org/10.5812/aapm-134806","url":null,"abstract":"<p><strong>Background: </strong>Uncontrolled elevation of intraoperative blood pressure can result in deleterious effects with increased risk of morbidity and mortality.</p><p><strong>Objectives: </strong>We aimed to compare nitroglycerine infusion with dexmedetomidine infusion in controlling accidental intraoperative uncontrolled hypertension.</p><p><strong>Methods: </strong>This comparative study was conducted on 73 hypertensive patients undergoing cancer surgeries who experienced uncontrolled intraoperative hypertension. The data of 38 patients were retrieved from the medical records for the nitroglycerine group and 35 patients were prospectively enrolled for the dexmedetomidine group. Group N received nitroglycerine infusion (0.3 - 1 µg/kg/min), while group D received dexmedetomidine infusion (0.2 - 0.7 µg/kg/h).</p><p><strong>Results: </strong>Both groups were comparable regarding their demographic data and clinical characteristics. Systolic, diastolic, and mean arterial pressure (MAP) values were significantly lower in group N compared to group D during the period between 60 and 120 minutes intraoperatively (P < 0.001). Heart rate values were significantly lower in group D than in group N (P < 0.001). Postoperative sedation scores were better for group D with lower analgesic requirements (P < 0.001).</p><p><strong>Conclusions: </strong>Dexmedetomidine infusion can be used to manage the uncontrolled intraoperative elevation of blood pressure in selected patient population.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e134806"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/56/aapm-13-2-134806.PMC10439692.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10040825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Laryngeal Mask Airway on Image Quality in Pediatric Patients Undergoing Brain Magnetic Resonance Imaging: A Randomized Controlled Trial. 喉罩气道对儿童脑磁共振成像图像质量的影响:一项随机对照试验。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-129532
Mohamed A Wadod, Omnia Mohammed Aboelazm, Mai Mohammed El Rawas

Background: Magnetic resonance imaging (MRI) is highly sensitive to motion, resulting in artifacts and lowering image quality. Laryngeal mask airway (LMA) provides numerous advantages over endotracheal tubes as it reduces laryngospasm, coughing, and the risk of postoperative desaturation.

Objectives: We aimed to compare LMA with oral airway for airway management during brain MRI in terms of reducing motion artifacts, which can improve image quality.

Methods: This randomized, controlled, double-blind trial was carried out on 40 pediatrics aged 1 - 18 years, American Society of Anesthesiologists (ASA) physical status І and П undergoing brain MRI. Patients were randomized into two equal groups according to the airway method, the control (Guedel oral airway) group and the LMA group. A compatible anesthesia machine was used to provide O2 and sevoflurane 2% - 4%.

Results: The mean MRI image quality score was significantly higher in the LMA group than in the control group (26.10 ± 3.97 versus 18.60 ± 5.30, P < 0.001). Mean arterial blood pressure and heart rate were significantly lower in the LMA group than in the control group at all study times except at baseline and immediate post-extubation (P < 0.05). Cough was significantly lower in LMA than in the control group (15% vs. 50%, P = 0.040). Airway complications (sore throat, laryngeal spasm, and bronchospasm), nausea, and vomiting did not have a significantly different between the two groups.

Conclusions: Compared to Guedel oral airway, using LMA for airway management in pediatrics undergoing MRI scans improved the image quality with less cough and better hemodynamics.

背景:磁共振成像(MRI)对运动高度敏感,导致伪影和降低图像质量。喉罩气道(LMA)与气管内插管相比有许多优点,因为它可以减少喉痉挛、咳嗽和术后去饱和的风险。目的:我们的目的是比较LMA与口腔气道在脑MRI期间气道管理方面减少运动伪影,从而提高图像质量。方法:对40名年龄在1 ~ 18岁、美国麻醉医师协会(ASA)身体状况І和П的儿童进行随机、对照、双盲试验。将患者按气道方法随机分为对照组(Guedel口腔气道)组和LMA组。配伍麻醉机供氧,七氟醚2% - 4%。结果:LMA组MRI图像质量平均评分明显高于对照组(26.10±3.97比18.60±5.30,P < 0.001)。除基线和拔管后即刻外,LMA组的平均动脉血压和心率在所有研究时间均显著低于对照组(P < 0.05)。LMA组咳嗽明显低于对照组(15% vs. 50%, P = 0.040)。气道并发症(喉咙痛、喉痉挛和支气管痉挛)、恶心和呕吐在两组间无显著差异。结论:与Guedel口腔气道相比,在接受MRI扫描的儿科患者中,使用LMA进行气道管理可以改善图像质量,减少咳嗽,改善血流动力学。
{"title":"Effect of Laryngeal Mask Airway on Image Quality in Pediatric Patients Undergoing Brain Magnetic Resonance Imaging: A Randomized Controlled Trial.","authors":"Mohamed A Wadod,&nbsp;Omnia Mohammed Aboelazm,&nbsp;Mai Mohammed El Rawas","doi":"10.5812/aapm-129532","DOIUrl":"https://doi.org/10.5812/aapm-129532","url":null,"abstract":"<p><strong>Background: </strong>Magnetic resonance imaging (MRI) is highly sensitive to motion, resulting in artifacts and lowering image quality. Laryngeal mask airway (LMA) provides numerous advantages over endotracheal tubes as it reduces laryngospasm, coughing, and the risk of postoperative desaturation.</p><p><strong>Objectives: </strong>We aimed to compare LMA with oral airway for airway management during brain MRI in terms of reducing motion artifacts, which can improve image quality.</p><p><strong>Methods: </strong>This randomized, controlled, double-blind trial was carried out on 40 pediatrics aged 1 - 18 years, American Society of Anesthesiologists (ASA) physical status І and П undergoing brain MRI. Patients were randomized into two equal groups according to the airway method, the control (Guedel oral airway) group and the LMA group. A compatible anesthesia machine was used to provide O<sub>2</sub> and sevoflurane 2% - 4%.</p><p><strong>Results: </strong>The mean MRI image quality score was significantly higher in the LMA group than in the control group (26.10 ± 3.97 versus 18.60 ± 5.30, P < 0.001). Mean arterial blood pressure and heart rate were significantly lower in the LMA group than in the control group at all study times except at baseline and immediate post-extubation (P < 0.05). Cough was significantly lower in LMA than in the control group (15% vs. 50%, P = 0.040). Airway complications (sore throat, laryngeal spasm, and bronchospasm), nausea, and vomiting did not have a significantly different between the two groups.</p><p><strong>Conclusions: </strong>Compared to Guedel oral airway, using LMA for airway management in pediatrics undergoing MRI scans improved the image quality with less cough and better hemodynamics.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e129532"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/58/91/aapm-13-2-129532.PMC10461386.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10475370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of Anesthetics on Cardiac Index and Metabolic Outcomes in Mitral and Aortic Valve Replacement in Adults: A Randomized Clinical Study. 麻醉药物对成人二尖瓣和主动脉瓣置换术中心脏指数和代谢结果的影响:一项随机临床研究
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-134119
Bekzat Askaruly Baiterek, Alibek Mustafin

Background: Cardiac index (CI) and metabolic response to surgery are important indicators of the course of the intraoperative period.

Objectives: This study aimed to determine the effect of sevoflurane, isoflurane, and propofol on CI and metabolic outcomes during aortic and mitral valve replacement in adults.

Methods: In this single-center prospective randomized controlled clinical study, a total of 75 patients were randomly assigned into 3 groups according to the type of anesthesia: The propofol group (n = 25), the sevoflurane group (n = 25), and the isoflurane group (n = 25). Cardiac stroke volume (SV) was determined by intraesophageal echocardiography (SV = end-diastolic volume - end-systolic volume). Cardiac output (CO) and CI were calculated according to the formulas. Oxygen consumption during surgery = CI × arteriovenous difference. Indirect calorimetry was used to determine energy expenditure during anesthesia using a spirometry device.

Results: The use of anesthetics did not change CI. Cardiac index decreased from 3 to 2.9 L/min/m2 in the propofol group, increased from 3.1 to 3.2 L/min/m2 in the sevoflurane group, and decreased from 2.9 to 2.7 L/min/m2 in the isoflurane group. Compared to inhaled anesthetics, propofol significantly reduced VO2 from 179.1 to 135.7 mL/min/m2. Propofol reduced energy expenditure from 1483.7 to 1333.5 kcal.

Conclusions: Volatile anesthetics, propofol has practically no effect on CI in an uncomplicated surgery. Anesthesia with propofol is associated with lower VO2 and better oxygen delivery to tissues. Energy consumption during propofol anesthesia decreases.

背景:心脏指数(CI)和手术代谢反应是术中病程的重要指标。目的:本研究旨在确定七氟醚、异氟醚和异丙酚对成人主动脉瓣和二尖瓣置换术中CI和代谢结果的影响。方法:采用单中心前瞻性随机对照临床研究,将75例患者按麻醉方式随机分为3组:异丙酚组(n = 25)、七氟醚组(n = 25)、异氟醚组(n = 25)。心搏容积(SV)通过食道超声心动图测定(SV =舒张末期容积-收缩末期容积)。按公式计算心输出量(CO)和CI。术中耗氧量= CI ×动静脉差。间接量热法用于使用肺活量测定装置测定麻醉期间的能量消耗。结果:麻醉药的使用没有改变CI。异氟醚组心脏指数从2.9 L/min/m2下降到2.9 L/min/m2,七氟醚组从3.1 L/min/m2上升到3.2 L/min/m2,异氟醚组从2.9 L/min/m2下降到2.7 L/min/m2。与吸入麻醉剂相比,异丙酚显著降低VO2,从179.1 mL/min/m2降至135.7 mL/min/m2。异丙酚使能量消耗从1483.7 kcal减少到1333.5 kcal。结论:挥发性麻醉药异丙酚在简单手术中对CI几乎没有影响。异丙酚麻醉与较低的VO2和更好的氧输送到组织有关。异丙酚麻醉期间能量消耗降低。
{"title":"Influence of Anesthetics on Cardiac Index and Metabolic Outcomes in Mitral and Aortic Valve Replacement in Adults: A Randomized Clinical Study.","authors":"Bekzat Askaruly Baiterek,&nbsp;Alibek Mustafin","doi":"10.5812/aapm-134119","DOIUrl":"https://doi.org/10.5812/aapm-134119","url":null,"abstract":"<p><strong>Background: </strong>Cardiac index (CI) and metabolic response to surgery are important indicators of the course of the intraoperative period.</p><p><strong>Objectives: </strong>This study aimed to determine the effect of sevoflurane, isoflurane, and propofol on CI and metabolic outcomes during aortic and mitral valve replacement in adults.</p><p><strong>Methods: </strong>In this single-center prospective randomized controlled clinical study, a total of 75 patients were randomly assigned into 3 groups according to the type of anesthesia: The propofol group (n = 25), the sevoflurane group (n = 25), and the isoflurane group (n = 25). Cardiac stroke volume (SV) was determined by intraesophageal echocardiography (SV = end-diastolic volume - end-systolic volume). Cardiac output (CO) and CI were calculated according to the formulas. Oxygen consumption during surgery = CI × arteriovenous difference. Indirect calorimetry was used to determine energy expenditure during anesthesia using a spirometry device.</p><p><strong>Results: </strong>The use of anesthetics did not change CI. Cardiac index decreased from 3 to 2.9 L/min/m<sup>2</sup> in the propofol group, increased from 3.1 to 3.2 L/min/m<sup>2</sup> in the sevoflurane group, and decreased from 2.9 to 2.7 L/min/m<sup>2</sup> in the isoflurane group. Compared to inhaled anesthetics, propofol significantly reduced VO<sub>2</sub> from 179.1 to 135.7 mL/min/m<sup>2</sup>. Propofol reduced energy expenditure from 1483.7 to 1333.5 kcal.</p><p><strong>Conclusions: </strong>Volatile anesthetics, propofol has practically no effect on CI in an uncomplicated surgery. Anesthesia with propofol is associated with lower VO<sub>2</sub> and better oxygen delivery to tissues. Energy consumption during propofol anesthesia decreases.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e134119"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/15/aapm-13-2-134119.PMC10439691.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10047208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Intramuscular Injection of Calcitonin on Pain Functional Status of Patients with Knee Osteoarthritis. 肌肉注射降钙素对膝关节骨性关节炎患者疼痛功能状况的影响。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-133992
Mehrdad Taheri, Faranak Behnaz, Mahshid Ghasemi

Background: Recently, increased attention has been paid to calcitonin for the management of osteoarthritis (OA) regarding its metabolic properties for bone turnover and cartilage.

Objectives: This study was designed to assess the efficacy of intramuscular calcitonin injection in the functional status of individuals suffering from knee OA.

Methods: A total of 40 eligible cases with OA were randomly assigned into intervention and control groups. At baseline, pain intensity and functional ability were evaluated based on the Numeric Rating scale (NRS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaires. Both groups were prescribed with AcetaGel (500 mg) and piroxicam (0.5% topical gel) every 8 hours as needed, and the patients were instructed about conservative treatments and lifestyle modifications. In the case group, the patients received calcitonin (50 IU/mL solution for injection; Aburaihan Pharmaceutical Co., Iran) intramuscularly (gluteal muscle) once a week for 4 consecutive weeks. One month after the last dose, the patients were evaluated based on NRS and WOMAC questionnaires.

Results: Demographic data did not show any statistically significant difference. A total of 40 cases (male and female) with mean age values of 53.10 ± 5.28 and 54.55 ± 5.26 years were included in the case and control groups, respectively. The mean body mass index values of the case and control groups were 27.45 ± 1.57 and 27.15 ± 1.53 kg/m2, respectively. After 1 month of treatment with calcitonin, significant improvements were observed in NRS outcomes (P < 0.001). The total WOMAC score was also statistically improved (P < 0.001).

Conclusions: The findings of the present study revealed that the weekly administration of 50 IU calcitonin for 28 days could significantly improve physical ability and pain intensity in OA patients.

背景:近年来,人们越来越关注降钙素在骨关节炎(OA)治疗中的作用,因为它对骨转换和软骨的代谢特性。目的:本研究旨在评估肌肉注射降钙素对膝关节OA患者功能状态的影响。方法:将40例符合条件的OA患者随机分为干预组和对照组。基线时,疼痛强度和功能能力根据数值评定量表(NRS)和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)问卷进行评估。两组患者均根据需要每8小时给予AcetaGel (500 mg)和piroxicam(0.5%外用凝胶),并指导患者保守治疗和改变生活方式。病例组患者给予降钙素(50iu /mL注射液;Aburaihan制药公司,伊朗)肌内注射(臀肌),每周1次,连续4周。末次给药1个月后,根据NRS和WOMAC问卷对患者进行评估。结果:两组人口统计学差异无统计学意义。病例组和对照组共40例,男女各40例,平均年龄分别为53.10±5.28岁和54.55±5.26岁。病例组和对照组的平均体重指数分别为27.45±1.57和27.15±1.53 kg/m2。降钙素治疗1个月后,NRS结果有显著改善(P < 0.001)。WOMAC总评分也有统计学差异(P < 0.001)。结论:本研究结果显示,每周给予50 IU降钙素,持续28天,可显著改善OA患者的身体能力和疼痛强度。
{"title":"Efficacy of Intramuscular Injection of Calcitonin on Pain Functional Status of Patients with Knee Osteoarthritis.","authors":"Mehrdad Taheri,&nbsp;Faranak Behnaz,&nbsp;Mahshid Ghasemi","doi":"10.5812/aapm-133992","DOIUrl":"https://doi.org/10.5812/aapm-133992","url":null,"abstract":"<p><strong>Background: </strong>Recently, increased attention has been paid to calcitonin for the management of osteoarthritis (OA) regarding its metabolic properties for bone turnover and cartilage.</p><p><strong>Objectives: </strong>This study was designed to assess the efficacy of intramuscular calcitonin injection in the functional status of individuals suffering from knee OA.</p><p><strong>Methods: </strong>A total of 40 eligible cases with OA were randomly assigned into intervention and control groups. At baseline, pain intensity and functional ability were evaluated based on the Numeric Rating scale (NRS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaires. Both groups were prescribed with AcetaGel (500 mg) and piroxicam (0.5% topical gel) every 8 hours as needed, and the patients were instructed about conservative treatments and lifestyle modifications. In the case group, the patients received calcitonin (50 IU/mL solution for injection; Aburaihan Pharmaceutical Co., Iran) intramuscularly (gluteal muscle) once a week for 4 consecutive weeks. One month after the last dose, the patients were evaluated based on NRS and WOMAC questionnaires.</p><p><strong>Results: </strong>Demographic data did not show any statistically significant difference. A total of 40 cases (male and female) with mean age values of 53.10 ± 5.28 and 54.55 ± 5.26 years were included in the case and control groups, respectively. The mean body mass index values of the case and control groups were 27.45 ± 1.57 and 27.15 ± 1.53 kg/m<sup>2</sup>, respectively. After 1 month of treatment with calcitonin, significant improvements were observed in NRS outcomes (P < 0.001). The total WOMAC score was also statistically improved (P < 0.001).</p><p><strong>Conclusions: </strong>The findings of the present study revealed that the weekly administration of 50 IU calcitonin for 28 days could significantly improve physical ability and pain intensity in OA patients.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e133992"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/e4/aapm-13-2-133992.PMC10439726.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10047209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Transversus Abdominis Plane Block for Postoperative Analgesia in Different Lower Abdominal Surgeries in a Tertiary Care Hospital-Chengalpattu District. 经腹平面阻滞在成都市某三级医院不同下腹部手术术后镇痛效果观察
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-134864
Murali Manoj Manoharan, Uma Gnanadesikan, Karthikeyan Elavarasan, Kumaran Nahendran

Background: Transversus abdominis plane (TAP) block is one of the novel approaches and an effective method for providing postoperative analgesia in patients undergoing lower abdominal surgeries.

Objectives: To evaluate the efficacy and routine usage of TAP block for postoperative analgesia in different lower abdominal surgeries.

Methods: It is a randomized, double-blind trial. Sixty patients undergoing lower abdominal surgeries in sub-arachnoid block with bupivicaine 0.5% were randomized to undergo TAP block (n = 30) using ropivacaine 0.375% as the study group. In the control group (n = 30), only the standard analgesic regimen (paracetamol 1 gm IV and tramadol 50 mg IV) was given. Postoperative pain was assessed using Visual Analogue Scale (VAS) at 30 min and 4, 8, 12, 16, 20, and 24 hrs. First analgesic request after TAP block was compared with a subsequent number of analgesics given postoperatively. Rescue analgesia given postoperatively at request after TAP block was paracetamol 1 gm IV and tramadol 50 mg IV.

Results: Patients who received TAP block had a significant reduction in postoperative pain scores at 30 min - 0 (0 - 1), 4 hrs - 0 (0 - 4), 8 hrs - 4 (3 - 5), 12 hrs - 1 (0 - 4), 16 hrs - 1 (1 - 2), 20 hrs -1 (0 - 2), 24 hrs -1 (0 - 1) with P-value < 0.05 in the first 24 hrs. TAP block also delayed the first rescue analgesic request (265 ± 24 min Vs. 66 ± 15 min with P-value < 0.005) and reduction in subsequent analgesic requirements in the first 24 hrs (1.04 ± 0.26 Vs. 2.3 ± 0.48 with P-value < 0.05).

Conclusions: TAP block holds a considerable part in postoperative analgesia. Highly effective for the first 24 hrs in patients undergoing different lower abdominal surgeries, it delays the first rescue analgesic request, decreases the subsequent analgesic requirement, and augments early mobilization, discharge, and cost-effectiveness.

背景:腹横面阻滞是下腹部手术患者术后镇痛的新途径和有效方法之一。目的:探讨TAP阻滞在不同类型下腹部手术中术后镇痛的效果及常规应用。方法:随机、双盲试验。采用0.5%布比卡因蛛网膜下阻滞下腹部手术患者60例,随机分为0.375%罗哌卡因TAP阻滞组(n = 30)。对照组(n = 30)仅给予标准镇痛方案(扑热息痛1 gm IV、曲马多50 mg IV)。术后疼痛采用视觉模拟评分(VAS)在30分钟和4、8、12、16、20和24小时进行评估。将TAP阻断后的首次镇痛请求与术后给予的镇痛数量进行比较。救援术后镇痛给定请求后利用第四块是扑热息痛1通用和曲马多50毫克IV.Results:病人利用块也显著减少术后疼痛得分在30分钟- 0(0 - 1),4小时- 0(0 - 4),8小时- 4(3 - 5),12小时- 1(0 - 4),16小时- 1(1 - 2),20小时1(0 - 2),24小时1(0 - 1)与p值< 0.05在第一个24小时。TAP阻滞还延迟了首次救援镇痛请求(265±24 min Vs. 66±15 min, p值< 0.005),并在最初24小时内减少了随后的镇痛需求(1.04±0.26 Vs. 2.3±0.48,p值< 0.05)。结论:TAP阻滞在术后镇痛中起着重要作用。在接受不同下腹部手术的患者的前24小时内非常有效,它延迟了首次救援镇痛请求,减少了随后的镇痛需求,并增加了早期动员、出院和成本效益。
{"title":"Efficacy of Transversus Abdominis Plane Block for Postoperative Analgesia in Different Lower Abdominal Surgeries in a Tertiary Care Hospital-Chengalpattu District.","authors":"Murali Manoj Manoharan,&nbsp;Uma Gnanadesikan,&nbsp;Karthikeyan Elavarasan,&nbsp;Kumaran Nahendran","doi":"10.5812/aapm-134864","DOIUrl":"https://doi.org/10.5812/aapm-134864","url":null,"abstract":"<p><strong>Background: </strong>Transversus abdominis plane (TAP) block is one of the novel approaches and an effective method for providing postoperative analgesia in patients undergoing lower abdominal surgeries.</p><p><strong>Objectives: </strong>To evaluate the efficacy and routine usage of TAP block for postoperative analgesia in different lower abdominal surgeries.</p><p><strong>Methods: </strong>It is a randomized, double-blind trial. Sixty patients undergoing lower abdominal surgeries in sub-arachnoid block with bupivicaine 0.5% were randomized to undergo TAP block (n = 30) using ropivacaine 0.375% as the study group. In the control group (n = 30), only the standard analgesic regimen (paracetamol 1 gm IV and tramadol 50 mg IV) was given. Postoperative pain was assessed using Visual Analogue Scale (VAS) at 30 min and 4, 8, 12, 16, 20, and 24 hrs. First analgesic request after TAP block was compared with a subsequent number of analgesics given postoperatively. Rescue analgesia given postoperatively at request after TAP block was paracetamol 1 gm IV and tramadol 50 mg IV.</p><p><strong>Results: </strong>Patients who received TAP block had a significant reduction in postoperative pain scores at 30 min - 0 (0 - 1), 4 hrs - 0 (0 - 4), 8 hrs - 4 (3 - 5), 12 hrs - 1 (0 - 4), 16 hrs - 1 (1 - 2), 20 hrs -1 (0 - 2), 24 hrs -1 (0 - 1) with P-value < 0.05 in the first 24 hrs. TAP block also delayed the first rescue analgesic request (265 ± 24 min Vs. 66 ± 15 min with P-value < 0.005) and reduction in subsequent analgesic requirements in the first 24 hrs (1.04 ± 0.26 Vs. 2.3 ± 0.48 with P-value < 0.05).</p><p><strong>Conclusions: </strong>TAP block holds a considerable part in postoperative analgesia. Highly effective for the first 24 hrs in patients undergoing different lower abdominal surgeries, it delays the first rescue analgesic request, decreases the subsequent analgesic requirement, and augments early mobilization, discharge, and cost-effectiveness.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e134864"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/97/aapm-13-2-134864.PMC10439687.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10049717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Preoperative Intravenous Iron and Erythropoietin Treatment and Outcomes in Cardiac Surgery Patients. 评估心脏手术患者术前静脉注射铁和促红细胞生成素治疗及预后。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-130899
Alireza Jahangirifard, Azita Chegini, Amirhossein Maghari

Background: Anemia is more common in cardiac surgery patients than in other people. Severe anemia before cardiac surgery strongly predicts blood transfusion.

Objectives: This study aimed to evaluate the outcomes of Intravenous (IV) iron and erythropoietin (EPO) injection preoperatively in anemic patients waiting for coronary artery bypass graft (CABG) surgery.

Methods: This cross-sectional study was performed between May to December 2020 at Masih Daneshvari hospital in Tehran, Iran. Anemia was described according to the WHO definition (Hb < 130 g/L in men). The study was designed in two groups of men CABG patients. Hematocrit level, platelet count, partial thromboplastin time, international normalized ratio, prothrombin time before surgery, red blood cells (RBCs) transfusion, as well as plasma and platelet units' transfusion during surgery and at the time of hospitalization were obtained from patient's files. The length of stay in the hospital and the consequences, including infection, stroke and heart attack, and mortality, were also obtained from the patient's files and recorded in the checklists. Pearson's chi-squared test, Fisher's exact test, independent samples t-test, univariate logistic regression, and odds ratio (OR) were used. All statistical analyses were performed by the SPSS software version 21. The significance level in this study was considered 0.05.

Results: In this study, the data of 64 patients were gathered, among whom 16 (25%) were injected with IV iron and EPO, and the remaining 48 (75%) did not receive any medications for stimulating erythropoiesis. The mean age of patients was 64.05 ± 8.21 years, with an age range of 51 - 91 years. Infection (P = 0.258) and mortality rate (P = 0.440) in the two groups of injection and non-injection did not show a statistically significant difference. The duration of the clamp at the time of surgery (r = 0.699, P = 0.001) and the duration of hospitalization (r = 0.399, P = 0.023) had statistically significant positive relationships with the pump duration. Red blood cell consumption in the injection and non-injection groups was 2.50 ± 2.07 and 2.90 ± 1.80 (P = 0.469), respectively.

Conclusions: Infection (P = 0.258), mortality rate (P = 0.440), and RBC utilization (P = 0.469) in the two groups of injection and non-injection were not significantly different.

背景:贫血在心脏手术患者中比在其他人群中更常见。心脏手术前的严重贫血很可能预示着输血。目的:本研究旨在评价术前静脉注射铁和促红细胞生成素(EPO)在等待冠状动脉搭桥术(CABG)的贫血患者中的效果。方法:本横断面研究于2020年5月至12月在伊朗德黑兰Masih Daneshvari医院进行。根据世界卫生组织的定义(男性Hb < 130 g/L)描述贫血。这项研究是在两组男性CABG患者中设计的。从患者档案中获取患者的红细胞压积水平、血小板计数、部分凝血活素时间、国际标准化比值、术前凝血酶原时间、红细胞输注、术中及住院时血浆和血小板单位输注情况。住院时间和后果,包括感染、中风和心脏病发作以及死亡率,也从病人的档案中获得并记录在检查清单中。采用Pearson卡方检验、Fisher精确检验、独立样本t检验、单因素logistic回归和比值比(OR)。所有统计分析均采用SPSS软件21版进行。本研究的显著性水平为0.05。结果:本研究共收集64例患者的资料,其中16例(25%)注射了静脉注射铁和促红细胞生成素,其余48例(75%)未接受任何促红细胞生成素药物治疗。患者平均年龄64.05±8.21岁,年龄范围51 ~ 91岁。注射组和非注射组的感染率(P = 0.258)和死亡率(P = 0.440)差异无统计学意义。手术时钳夹时间(r = 0.699, P = 0.001)、住院时间(r = 0.399, P = 0.023)与泵浦时间呈正相关,有统计学意义。注射组和非注射组红细胞消耗分别为2.50±2.07和2.90±1.80 (P = 0.469)。结论:注射组与非注射组感染(P = 0.258)、死亡率(P = 0.440)、红细胞利用率(P = 0.469)差异无统计学意义。
{"title":"Evaluating Preoperative Intravenous Iron and Erythropoietin Treatment and Outcomes in Cardiac Surgery Patients.","authors":"Alireza Jahangirifard,&nbsp;Azita Chegini,&nbsp;Amirhossein Maghari","doi":"10.5812/aapm-130899","DOIUrl":"https://doi.org/10.5812/aapm-130899","url":null,"abstract":"<p><strong>Background: </strong>Anemia is more common in cardiac surgery patients than in other people. Severe anemia before cardiac surgery strongly predicts blood transfusion.</p><p><strong>Objectives: </strong>This study aimed to evaluate the outcomes of Intravenous (IV) iron and erythropoietin (EPO) injection preoperatively in anemic patients waiting for coronary artery bypass graft (CABG) surgery.</p><p><strong>Methods: </strong>This cross-sectional study was performed between May to December 2020 at Masih Daneshvari hospital in Tehran, Iran. Anemia was described according to the WHO definition (Hb < 130 g/L in men). The study was designed in two groups of men CABG patients. Hematocrit level, platelet count, partial thromboplastin time, international normalized ratio, prothrombin time before surgery, red blood cells (RBCs) transfusion, as well as plasma and platelet units' transfusion during surgery and at the time of hospitalization were obtained from patient's files. The length of stay in the hospital and the consequences, including infection, stroke and heart attack, and mortality, were also obtained from the patient's files and recorded in the checklists. Pearson's chi-squared test, Fisher's exact test, independent samples <i>t</i>-test, univariate logistic regression, and odds ratio (OR) were used. All statistical analyses were performed by the SPSS software version 21. The significance level in this study was considered 0.05.</p><p><strong>Results: </strong>In this study, the data of 64 patients were gathered, among whom 16 (25%) were injected with IV iron and EPO, and the remaining 48 (75%) did not receive any medications for stimulating erythropoiesis. The mean age of patients was 64.05 ± 8.21 years, with an age range of 51 - 91 years. Infection (P = 0.258) and mortality rate (P = 0.440) in the two groups of injection and non-injection did not show a statistically significant difference. The duration of the clamp at the time of surgery (r = 0.699, P = 0.001) and the duration of hospitalization (r = 0.399, P = 0.023) had statistically significant positive relationships with the pump duration. Red blood cell consumption in the injection and non-injection groups was 2.50 ± 2.07 and 2.90 ± 1.80 (P = 0.469), respectively.</p><p><strong>Conclusions: </strong>Infection (P = 0.258), mortality rate (P = 0.440), and RBC utilization (P = 0.469) in the two groups of injection and non-injection were not significantly different.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e130899"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/48/10/aapm-13-2-130899.PMC10461381.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10175899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quadratus Lumborum Block Against Coupled Transversus Abdominis Block and Ilioinguinal/Iliohypogastric Nerve Blocks for Postoperative Analgesia After Total Abdominal Hysterectomy: A Randomized Controlled Trial. 腰方肌阻滞对抗经腹阻滞联合髂腹股沟/髂腹下神经阻滞用于全腹子宫切除术后的术后镇痛:一项随机对照试验。
Q2 Medicine Pub Date : 2023-04-01 DOI: 10.5812/aapm-134845
Amany Faheem Omara, Amr Arafa Elbadry, Alaa Mohammed Abo Hagar

Background: Nerve blocks have been one of the most common anesthetic methods for abdominal surgeries since the last four decades.

Objectives: This study aimed to compare the postoperative analgesic efficacy of bilateral ultrasound-guided quadratus lumborum block (QLB) against bilateral ultrasound-guided transversus abdominis block (TAB) and Ilioinguinal/Iliohypogastric nerve blocks (IINB) in abdominal total hysterectomy.

Methods: Sixty female patients scheduled for the surgery of total abdominal hysterectomy under spinal anesthesia participated in this randomized prospective trial. They were randomly assigned to two dual TAB / IINB (n = 30) and QLB (n = 30) groups. Moreover, the visual analog scores (VAS), the total amount of morphine consumed after surgery during the first 24 hours, the number of individuals requiring rescue analgesia, postoperative analgesia duration, and postoperative complications were recorded.

Results: Morphine consumption was equal in both groups (P = 0.908). Furthermore, the analgesia duration in the two groups was statistically insignificant (P = 0.879), with mean values of 15.4 and 15.6 hours, respectively. During 24 hours, there was no statistically significant difference in terms of VAS between the two groups (P > 0.05).

Conclusions: The QLB might be a viable replacement for TAB/IINB for postoperative analgesia after total abdominal hysterectomy.

背景:近四十年来,神经阻滞一直是腹部手术中最常用的麻醉方法之一。目的:比较双侧超声引导下腰方肌阻滞(QLB)与双侧超声引导下经腹阻滞(TAB)及髂腹股沟/髂腹下神经阻滞(IINB)在腹部全子宫切除术中的术后镇痛效果。方法:60例脊柱麻醉下腹式全子宫切除术的女性患者参与了这项随机前瞻性试验。随机分为双TAB / IINB组(n = 30)和QLB组(n = 30)。记录两组视觉模拟评分(VAS)、术后24小时吗啡总用量、需要抢救性镇痛的人数、术后镇痛持续时间及术后并发症。结果:两组吗啡用量相等(P = 0.908)。两组患者镇痛时间差异无统计学意义(P = 0.879),平均分别为15.4、15.6小时。24小时内,两组患者VAS评分比较,差异无统计学意义(P > 0.05)。结论:QLB可替代TAB/IINB用于腹式全子宫切除术后镇痛。
{"title":"Quadratus Lumborum Block Against Coupled Transversus Abdominis Block and Ilioinguinal/Iliohypogastric Nerve Blocks for Postoperative Analgesia After Total Abdominal Hysterectomy: A Randomized Controlled Trial.","authors":"Amany Faheem Omara,&nbsp;Amr Arafa Elbadry,&nbsp;Alaa Mohammed Abo Hagar","doi":"10.5812/aapm-134845","DOIUrl":"https://doi.org/10.5812/aapm-134845","url":null,"abstract":"<p><strong>Background: </strong>Nerve blocks have been one of the most common anesthetic methods for abdominal surgeries since the last four decades.</p><p><strong>Objectives: </strong>This study aimed to compare the postoperative analgesic efficacy of bilateral ultrasound-guided quadratus lumborum block (QLB) against bilateral ultrasound-guided transversus abdominis block (TAB) and Ilioinguinal/Iliohypogastric nerve blocks (IINB) in abdominal total hysterectomy.</p><p><strong>Methods: </strong>Sixty female patients scheduled for the surgery of total abdominal hysterectomy under spinal anesthesia participated in this randomized prospective trial. They were randomly assigned to two dual TAB / IINB (n = 30) and QLB (n = 30) groups. Moreover, the visual analog scores (VAS), the total amount of morphine consumed after surgery during the first 24 hours, the number of individuals requiring rescue analgesia, postoperative analgesia duration, and postoperative complications were recorded.</p><p><strong>Results: </strong>Morphine consumption was equal in both groups (P = 0.908). Furthermore, the analgesia duration in the two groups was statistically insignificant (P = 0.879), with mean values of 15.4 and 15.6 hours, respectively. During 24 hours, there was no statistically significant difference in terms of VAS between the two groups (P > 0.05).</p><p><strong>Conclusions: </strong>The QLB might be a viable replacement for TAB/IINB for postoperative analgesia after total abdominal hysterectomy.</p>","PeriodicalId":7841,"journal":{"name":"Anesthesiology and Pain Medicine","volume":"13 2","pages":"e134845"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/ec/aapm-13-2-134845.PMC10439688.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10049720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anesthesiology and Pain Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1